Clinical characteristics of α-pyrrolidinovalerophenone (α-PVP) poisoning

References

• Hyde JF, Browning E, Adams R. Synthetic homologs of d,l-ephedrine. J Am Chem Soc. 1928;50:2287–2292.
   Google Scholar
• Davies S, Wood DM, Smith G, et al. Purchasing 'legal highs' on the Internet–is there consistency in what you get? QJM. 2010;103:489–493.
   PubMed Web of Science ®Google Scholar
• Stogner JM, Miller BL. Investigating the 'bath salt' panic: the rarity of synthetic cathinone use among students in the United States. Drug Alcohol Rev. 2013;32:545–549.
   PubMed Web of Science ®Google Scholar
• Kikura-Hanajiri R, Kawamura NU, Goda Y. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan. Drug Test Anal. 2014;6:832–839.
   PubMed Web of Science ®Google Scholar
• Marinetti LJ, Antonides HM. Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol. 2013;37:135–146.
   PubMed Web of Science ®Google Scholar
• Nelson ME, Bryant SM, Aks SE. Emerging drugs of abuse. Emerg Med Clin North Am. 2014;32:1–28.
   PubMed Web of Science ®Google Scholar
• Meltzer PC, Butler D, Deschamps JR, Madras BK. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem. 2006;49:1420–1432.
   PubMed Web of Science ®Google Scholar
• Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol. 2012;8:33–42.
   PubMedGoogle Scholar
• EMCDDA. Europol Joint Report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-penteanone (α-PVP) 2015 [Internet]; [cited 2016 May 16]. Available from: http://www.emcdda.europa.eu/attachements.cfm/att_242501_EN_TDAS15001ENN.pdf.
   Google Scholar
• Saito T, Namera A, Osawa M, et al. SPME-GC-MS analysis of α-pyrrolidinovaleorophenone in blood in a fatal poisoning case. Forensic Toxicol. 2013;31:328–332.
   Web of Science ®Google Scholar
• Sykutera M, Cychowska M, Bloch-Boguslawska E. A fatal case of pentedrone and alpha-pyrrolidinovalerophenone poisoning. J Anal Toxicol. 2015;39:9–32.
   Web of Science ®Google Scholar
• Eiden C, Mathieu O, Cathala P, et al. Toxicity and death following recreational use of 2-pyrrolidino valerophenone. Clin Toxicol (Phila). 2013;51:899–903.
   PubMed Web of Science ®Google Scholar
• Minakata K, Yamagishi I, Nozawa H, et al. MALDI-TOF mass spectrometric determination of four pyrrolidino cathinones in human blood. Forensic Toxicol. 2014;32:169–175.
   Web of Science ®Google Scholar
• Knoy JL, Peterson BL, Couper FJ. Suspected impaired driving case involving α-pyrrolidinovalerophenone, methylone and ethylone. J Anal Toxicol. 2014;38:615–617.
   PubMed Web of Science ®Google Scholar
• Sellors K, Jones A, Chan B. Death due to intravenous use of α-pyrrolidinopentiophenone. Med J Aust. 2014;201:601–603.
   PubMed Web of Science ®Google Scholar
• Dragogna F, Oldani L, Buoli M, Altamura AC. A case of severe psychosis induced by novel recreational drugs. F1000Res. 2014;3:21.
   PubMedGoogle Scholar
• Hasegawa K, Suzuki O, Wurita A. Postmortem distribution of α-pyrrolidinovalerophenone and its metabolism in body fluids and solid tissues in a fatal poisonins case measured by LC-MS-MS with the standard addition method. Forensic Toxicol. 2014;32:225–234.
   Web of Science ®Google Scholar
• Namera A, Uraba S, Saito T. A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α-pyrrolidinovalerophenone in blood and/or hair. Forensic Toxicol. 2013;31:338–343.
   Web of Science ®Google Scholar
• Kevin GS, George SB, Andrea R. Detection of alpha-PVP in postmortem blood casework by UPLC/MS/MS. Proceedings of the Society of Forensic Toxicologists; 2013. p. 12.
   Google Scholar
• Nagai H, Saka K, Nakajima M, et al. Sudden death after sustained restraint following self-administration of the designer drug α-pyrrolidinobutiophenone. Int J Cardiol. 2014;172:263–265.
   PubMed Web of Science ®Google Scholar
• Khan S, Shaheen F, Sawar H, et al. “Bath salts”-induced psychosis in a young woman. Prim Care Companion CNS Disord. 2013;15:12101417. PCC.
   Google Scholar
• German CL, Fleckenstein AE, Hanson GR. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci. 2014;97:2–8.
   PubMed Web of Science ®Google Scholar
• Wada K. Citizen survey of drug use 2013. National Center of Neurology and Psychiatry [Internet]; [cited 2016 May 16]. Available from: http://www.ncnp.go.jp/nimh/yakubutsu/drug-top/data/researchJDU2013.pdf.
   Google Scholar
• Behavioral Health Barometer, United States, 2015 Substance abuse and mental health services administration [Internet]; [cited 2016 May 16]. Available from: http://www.samhsa.gov/data/sites/default/files/2015_National_Barometer.pdf.
   Google Scholar
• Gibbons S, Zloh M. An analysis of the 'legal high' mephedrone. Bioorg Med Chem Lett. 2010;20:4135–4139.
   PubMed Web of Science ®Google Scholar
• Cozzi NV, Sievert MK, Shulgin AT, et al. Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol. 1999;381:63–69.
   PubMed Web of Science ®Google Scholar
• Marusich JA, Antonazzo KR, Wiley JL, et al. Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology. 2014;87:206–213.
   PubMed Web of Science ®Google Scholar
• Rickli A, Hoener MC, Liechti ME. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones. Eur Neuropsychopharmacol. 2015;25:365–376.
   PubMed Web of Science ®Google Scholar
• Zaitsu K, Katagi M, Tsuchihashi H, et al. Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: a review of their pharmacology, acute poisoning, and metabolism. Forensic Toxicol. 2014;32:1–8.
   Web of Science ®Google Scholar
• James D, Adams RD, Spears R, et al. Clinical characteristics of mephedrone poisoning reported to the U.K. National Poisons Information Service. Emerg Med J. 2011;28:686–689.
   PubMed Web of Science ®Google Scholar